Table 1.

Results of analysis of colony-stimulating activity in the patient's serum

StimulusGM-CFCsMeg-CFCsErythroid colonies
Donor 1Donor 2Donor 1Donor 2Donor 1Donor 2
None 0  
None + patient's serum 7 ± 1 5 ± 2 2 ± 1 15 ± 4 
Growth factors 30 ± 2 21 ± 1 2.7 ± 0.2 1.7 ± 0.1 34 ± 1 58 ± 1 
Growth factors + patient's serum 44 ± 4 60 ± 3 1.6 ± 0.1 4.2 ± 0.2 51 ± 5 65 ± 2 
StimulusGM-CFCsMeg-CFCsErythroid colonies
Donor 1Donor 2Donor 1Donor 2Donor 1Donor 2
None 0  
None + patient's serum 7 ± 1 5 ± 2 2 ± 1 15 ± 4 
Growth factors 30 ± 2 21 ± 1 2.7 ± 0.2 1.7 ± 0.1 34 ± 1 58 ± 1 
Growth factors + patient's serum 44 ± 4 60 ± 3 1.6 ± 0.1 4.2 ± 0.2 51 ± 5 65 ± 2 

Shown are results from replicate cultures using bone marrow samples from 2 healthy donors. Cells (104/mL) were incubated with no stimulus, 10% patient's serum, a combination of growth factors (granulocyte-macrophage [GM] colony-stimulating factor, granulocyte colony-stimulating factor, erythropoietin, interleukin 6, stem-cell factor, and pegylated recombinant human megakaryocyte growth and development factor), or a mixture of these stimuli. Erythroid-stimulating activity and GM-stimulating activity were present in the patient's serum samples.

GM-CFCs indicates GM colony-forming cells; Meg-CFCs, megakaryocyte colony-forming cells.

Close Modal

or Create an Account

Close Modal
Close Modal